BBA
DSCI

Baker Bros. Advisors’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Baker Bros. Advisors’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,752,390
Closed -$19.5M – 137
2016
Q4 		$19.5M Hold
3,752,390
– – 0.19% 35
2016
Q3 		$17.5M Hold
3,752,390
– – 0.16% 39
2016
Q2 		$14.8M Hold
3,752,390
– – 0.16% 43
2016
Q1 		$11.6M Hold
3,752,390
– – 0.12% 53
2015
Q4 		$17.1M Buy
3,752,390
+294,549
+9% +$1.4M 0.14% 50
2015
Q3 		$16.3M Hold
3,457,841
– – 0.15% 47
2015
Q2 		$24.8M Hold
3,457,841
– – 0.22% 43
2015
Q1 		$29.3M Sell
3,457,841
-79,296
-2% -$675K 0.24% 35
2014
Q4 		$32.9M Hold
3,537,137
– – 0.34% 30
2014
Q3 		$29.5M Hold
3,537,137
– – 0.37% 27
2014
Q2 		$40.9M Hold
3,537,137
– – 0.5% 27
2014
Q1 		$44.9M Buy
3,537,137
+978,280
+38% +$12.6M 0.57% 27
2013
Q4 		$27.7M Hold
2,558,857
– – 0.39% 30
2013
Q3 		$31.7M Buy
2,558,857
+1,200,000
+88% +$16.6M 0.45% 25
2013
Q2 		$18.1M Buy
+1,358,857
New +$17.5M 0.36% 29

Other funds holding DSCI

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Baker Bros. Advisors's DSCI Position: Q1 2017 in Review

Baker Bros. Advisors sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 3,752,390 shares — an estimated $19.5M sold.

Baker Bros. Advisors first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $44.9M in Q1 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • Baker Bros. Advisors reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • Baker Bros. Advisors sold 3,752,390 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $19.5M.
  • Baker Bros. Advisors first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 15 quarters.
  • Baker Bros. Advisors's Derma Sciences, Inc. Common Stock (DE) position peaked at $44.9M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Baker Bros. Advisors's 13F filing for Q1 2017, filed 15 May 2017.